In ED vitals were stable with sats 100% on 1.5L o2 and bp of 134/89, temp 99.4. labs are at baseline.
CXR revealed moderate to large left sided pleural effusion with pleurex drain and minimal interval changes.
Past Medical History: [**7-/2159**]: Diagnosed with non small cell lung cancer by CT guided biopsy [**2159-9-20**]: PET scan with low-attenuation lesion in the left lobe of the thyroid gland measuring 25 x 7 mm in addition to markedly FDG avid left upper lobe mass consistent with known cancer and FDG avid prominent bilateral axillary lymphadenopathy suspicious for metastatic disease, but no pathologically enlarged infraclavicular lymph nodes.
[**2160-7-24**]: CT demonstrated left upper lobe mass minimally increased in size from [**3-/2160**] with a sub 5 mm left upper lobe pulmonary nodule with additional stable bilateral nodules, new left-sided pleural effusion.
Pathology revealed 4R lymph nodes with no malignancy but frozen sections showed metastatic large cell carcinoma and 4L lymph nodes that showed metastatic large cell carcinoma.
A level 7 lymph node showed metastatic large cell carcinoma and a parietal pleural biopsy also showed metastatic large cell carcinoma involving the pleura.
MEDICAL HISTORY: - Peripheral vestibulopathy - HIV: Diagnosed in the [**2142**], he had been previously cared for by Dr. [**First Name8 (NamePattern2) 333**] [**Last Name (NamePattern1) 42604**] at [**Hospital6 **].
[**2160-10-30**] -> CD4 425, VL undetectable - Positive PPD-negative AFB [**1-11**]-s/p 6 months Rifampin in [**2148**].
Exam at discharge: O:  126/88  99  99.1  98% RA   1154/1520 Gen: Pleasant, chronically ill appearing male in NAD HEENT: No conjunctival pallor.
Pertinent Results: [**2161-10-18**]  WBC-10.7  Hgb-9.8* Hct-30.9*   Plt Ct-577* [**2161-10-19**]  WBC-3.6*#  Hgb-8.6* Hct-25.8*   Plt Ct-397 [**2161-10-19**]  WBC-2.3*  Hgb-9.6* Hct-29.3*   Plt Ct-379 [**2161-10-20**]  WBC-1.5*  Hgb-9.0* Hct-27.7*   Plt Ct-319 [**2161-10-21**]  WBC-2.1*  Hgb-9.1* Hct-27.4*   Plt Ct-257 [**2161-10-22**]  WBC-2.9*  Hgb-8.6* Hct-26.6*   Plt Ct-220 [**2161-10-23**]  WBC-3.8*  Hgb-8.9* Hct-27.3*   Plt Ct-169 [**2161-10-24**]  WBC-3.9*  Hgb-8.2* Hct-25.4*   Plt Ct-167 [**2161-10-24**]  WBC-4.0  Hgb-8.5* Hct-26.9*   Plt Ct-153 [**2161-10-25**]  WBC-4.5  Hgb-7.4* Hct-21.9*   Plt Ct-178 [**2161-10-26**]  WBC-5.5  Hgb-7.9* Hct-24.0*   Plt Ct-182 [**2161-10-27**]  WBC-6.4  Hgb-9.2* Hct-26.7*   Plt Ct-172 [**2161-10-28**]  WBC-7.0  Hgb-9.8* Hct-28.6*   Plt Ct-227 [**2161-10-29**]  WBC-8.5  Hgb-9.6* Hct-28.7*   Plt Ct-279 [**2161-10-30**]  WBC-8.3  Hgb-9.4* Hct-29.7*   Plt Ct-359 [**2161-10-31**]  WBC-7.8  Hgb-9.8* Hct-29.6*   Plt Ct-458* [**2161-11-1**]  WBC-7.9  Hgb-9.3* Hct-28.5*   Plt Ct-521* [**2161-11-2**]  WBC-5.8  Hgb-9.7* Hct-29.3*   Plt Ct-595* [**2161-11-4**]  WBC-6.8  Hgb-9.3* Hct-29.4*   Plt Ct-676* [**2161-11-5**]  WBC-7.5  Hgb-9.0* Hct-28.0*   Plt Ct-656*  [**2161-10-28**]   WBC-7.0 Lymph-43* Abs [**Last Name (un) **]-3010 CD3%-78 Abs CD3-2339* CD4%-16 Abs CD4-483 CD8%-61 Abs CD8-1824* CD4/CD8-0.3*  [**2161-10-18**]   UreaN-11 Creat-1.2 Na-136 K-4.6 Cl-96 HCO3-28 AnGap-17 [**2161-10-19**]   UreaN-10 Creat-1.1 Na-139 K-3.8 Cl-102 HCO3-30 AnGap-11 [**2161-10-20**]   UreaN-6 Creat-1.2 Na-140 K-3.7 Cl-103 HCO3-30 AnGap-11 [**2161-10-21**]   UreaN-11 Creat-1.4* Na-142 K-3.8 Cl-102 HCO3-31 AnGap-13 [**2161-10-22**]   UreaN-9 Creat-1.4* Na-141 K-3.7 Cl-100 HCO3-31 AnGap-14 [**2161-10-23**]   UreaN-8 Creat-1.6* Na-141 K-4.0 Cl-104 HCO3-30 AnGap-11 [**2161-10-23**]   UreaN-8 Creat-1.6* Na-138 K-3.9 Cl-100 HCO3-29 AnGap-13 [**2161-10-24**]   UreaN-7 Creat-1.7* Na-139 K-3.6 Cl-101 HCO3-30 AnGap-12 [**2161-10-25**]   UreaN-7 Creat-1.7* Na-138 K-4.0 Cl-100 HCO3-30 AnGap-12 [**2161-10-26**]   UreaN-10 Creat-2.0* Na-139 K-4.0 Cl-100 HCO3-31 AnGap-12 [**2161-10-27**]   UreaN-13 Creat-2.0* Na-140 K-4.2 Cl-103 HCO3-29 AnGap-12 [**2161-10-28**]   UreaN-10 Creat-2.0* Na-141 K-4.0 Cl-102 HCO3-30 AnGap-13 [**2161-10-29**]   UreaN-11 Creat-2.1* Na-143 K-4.0 Cl-105 HCO3-26 AnGap-16 [**2161-10-30**]   UreaN-11 Creat-2.3* Na-143 K-4.2 Cl-105 HCO3-29 AnGap-13 [**2161-10-31**]   UreaN-11 Creat-2.3* Na-141 K-4.2 Cl-105 HCO3-28 AnGap-12 [**2161-11-1**]   UreaN-12 Creat-2.3* Na-143 K-4.3 Cl-105 HCO3-30 AnGap-12 [**2161-11-2**]   UreaN-11 Creat-2.3* Na-145 K-4.3 Cl-105 HCO3-29 AnGap-15 [**2161-11-3**]   UreaN-9 Creat-1.9* Na-143 K-4.1 Cl-104 HCO3-29 AnGap-14 [**2161-11-4**]   UreaN-8 Creat-2.1* Na-147* K-4.3 Cl-108 HCO3-31 AnGap-12 [**2161-11-5**]   UreaN-9 Creat-1.8* Na-145 K-4.2 Cl-105 HCO3-32 AnGap-12  [**2161-10-24**]  ALT-97* AST-89* LD(LDH)-505* CK(CPK)-97 AP-288* Amylase-93 TotBili-5.1* [**2161-10-24**]  CK(CPK)-102 [**2161-10-25**]  ALT-79* AST-66* LD(LDH)-478* CK(CPK)-88 AP-246* Amylase-80 TotBili-4.4* DirBili-0.2 IndBili-4.2 [**2161-10-26**]  ALT-64* AST-53* AP-244* TotBili-4.2* [**2161-10-27**]  ALT-50* AST-43* LD(LDH)-497* AP-227* Amylase-78 TotBili-4.5* [**2161-10-28**]  ALT-41* AST-41* LD(LDH)-514* AP-230* TotBili-4.4* [**2161-10-29**]  ALT-37 AST-43* AP-236* TotBili-3.1* [**2161-10-30**]  ALT-58* AST-79* LD(LDH)-486* AP-406* TotBili-1.5 [**2161-10-31**]  ALT-44* AST-51* LD(LDH)-483* AP-371* TotBili-0.7 [**2161-11-1**]  ALT-45* AST-61* LD(LDH)-469* AP-402* TotBili-0.4 [**2161-11-4**]  ALT-86* AST-165* LD(LDH)-619* AP-465* TotBili-0.4 [**2161-11-5**]  ALT-59* AST-69* LD(LDH)-607* AP-409* TotBili-0.4  [**2161-10-24**]  CK-MB-2 cTropnT-<0.01 [**2161-10-24**]  CK-MB-2 cTropnT-<0.01 [**2161-10-25**]  CK-MB-2 cTropnT-<0.01 [**2161-10-28**]  Type-ART pO2-92 pCO2-26* pH-7.66* calTCO2-30 Base XS-9  [**2161-10-28**]  Type-ART pO2-26* pCO2-37 pH-7.53* calTCO2-32* Base XS-6 [**2161-10-29**]  Type-[**Last Name (un) **] pO2-43* pCO2-47* pH-7.45 calTCO2-34* Base XS-7 [**2161-10-30**]  Type-[**Last Name (un) **] pO2-154* pCO2-46* pH-7.45 calTCO2-33* Base XS-7 C [**2161-10-28**]  Lactate-1.1 Na-143 K-3.7 Cl-102 [**2161-10-28**]  Lactate-2.1* Na-144 K-3.8 Cl-101  [**2161-10-21**]  URINE Hours-RANDOM Creat-31 Na-31 K-13 Cl-30 [**2161-10-24**]  URINE Hours-RANDOM Creat-31 Na-24 [**2161-10-28**]  URINE Hours-RANDOM Creat-30 Na-49 K-16 Cl-39 [**2161-10-30**]  URINE Hours-RANDOM UreaN-126 Creat-45 Na-32 Phos-6.8 [**2161-10-28**]  URINE Osmolal-160 [**2161-10-30**]  URINE Osmolal-153 [**2161-10-20**]  PLEURAL WBC-600* RBC-8125* Polys-0 Lymphs-95* Monos-5* [**2161-10-21**]  PLEURAL WBC-889* RBC-[**Numeric Identifier 42605**]* Polys-1* Lymphs-89* Monos-6* Eos-1* Meso-2* Macro-1* [**2161-11-5**]  PLEURAL WBC-650* RBC-[**Numeric Identifier 42606**]* Polys-7* Lymphs-91* Monos-2* [**2161-10-20**]  PLEURAL TotProt-3.9 LD(LDH)-527 [**2161-10-20**]  PLEURAL TotProt-3.4 LD(LDH)-447 [**2161-10-21**]  PLEURAL TotProt-3.7 Glucose-119 LD(LDH)-430  CXR [**10-18**] IMPRESSION: Moderate to large left pleural effusion with related atelectasis unchanged.
CXR [**10-20**] 1.
CXR [**10-28**] FINDINGS: As compared to the previous examination, there is no relevant change.
CXR [**10-31**] IMPRESSION: Extensive left effusion; however, decreased compared to [**2161-10-28**].
CT head [**10-28**] 1.
Abdominal ultrasound [**11-4**] 1.
This is a concentrated smear made by cytospin method, please refer to       hematology for a quantitative white blood cell count..     FLUID CULTURE (Final [**2161-11-8**]):    NO GROWTH.
ANAEROBIC CULTURE (Preliminary):    NO GROWTH   Brief Hospital Course: 62 year old male with a h/o metastatic large cell lung cancer to bone c/b recurrent malignant pleural effusion requiring pleurex catheter placement, HIV (CD4 535) on HAART, htn who presented with dyspnea, unchanged pleural effusion on cxr and low grade fever.
Blood cultures were all negative and an echocardiogram showed no vegetations.
Disp:*30 packets* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: Primary Diagnosis: metastatic large cell lung cancer HIV/AIDS  Secondary Diagnoses: # stage IIIB large cell lung cancer metastatic to bone - started Alimenta [**2161-7-16**] # HIV, CD4 [**6-13**] 535, VL undetectable - diagnosed in [**2142**] - re-initiated HAART on [**2160-2-28**] # chronic malignant pleural effusion s/p talc pleurodesis [**8-12**] with pleurex catheter placed [**1-12**] for recurrent effusion # Hypertension # Positive PPD-negative AFB [**1-11**]-s/p 6 months Rifampin in [**2148**].
# Hepatitis B # s/p cholecystectomy on [**2161-4-1**] # h/o appendicitis status post appendectomy in [**2126**] # Sellar mass seen on MRI most recently on [**2160-8-4**] - a stable appearance of the intra and suprasellar mass - nonfunctioning mass as worked up by endocrinology # Low back pain     Discharge Condition: stable and improved   Discharge Instructions: You were admitted to the hospital for shortness of breath.
A CT scan of your chest showed that you did not have any blood clots in your lungs.
An endoscopic procedure showed that you had no inflammation in your esophagous, and some mild inflammation in your stomach.
An ultrasound of your abdomen also was normal.
Followup Instructions: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 7447**], MD Phone:[**Telephone/Fax (1) 457**] Date/Time:[**2161-11-18**] 11:30  please call your primary oncologist, Dr. [**Last Name (STitle) 3274**], at [**Telephone/Fax (1) 15512**], this week to set up a follow up appointment next week                                [**First Name8 (NamePattern2) 251**] [**Name8 (MD) **] MD [**MD Number(1) 3282**]
